Millennium's increased stake to 7.0% suggests growing conviction, but the passive filing status limits near-term catalyst potential. Watch for any future conversion to a 13D (activist filing) or additional accumulation above 10%, which would require more detailed disclosure.
Price Chart
Executive Summary
Millennium Management LLC filed an amended Schedule 13G disclosing a 7.0% passive stake in Vanda Pharmaceuticals as of September 30, 2026, with 4,260,038 shares held. This is an increase from the prior 13G filing 51 days ago, which did not specify a percentage but was also filed by Millennium. The stake growth signals continued conviction by a major multi-strategy hedge fund, though the passive filing indicates no activist intent.
Key Financial Metrics
Key Facts
- Millennium Management LLC reported beneficial ownership of 4,260,038 shares of Vanda Pharmaceuticals common stock as of September 30, 2026.
- The stake represents 7.0% of shares outstanding.
- This is an amendment to a prior Schedule 13G filed August 19, 2026, indicating an increase in position.
- The filing is made under Rule 13d-1(c) (passive investor), with a certification that the securities were not acquired to change or influence control.
- Millennium Group Management LLC and Israel A. Englander are also named as reporting persons.
Financial Impact
Millennium's stake of 4.26M shares at current market prices represents a meaningful position, but no dollar value is stated in the filing.
Risk Factors
- Millennium could reduce or exit the position at any time without notice, as a passive filer.
- No specific catalyst or timeline for value realization is provided in the filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-115112 |
| Document: 0001104659-26-115112-index-headers.html | 0001104659-26-115112 |
| Document: 0001104659-26-115112-index.html | 0001104659-26-115112 |
| Document: 0001104659-26-115112.txt | 0001104659-26-115112 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | SC 13G | $4.04 | awaiting T+20 | — | $3.99 (−1.24%) |
Oct 21, 2026 6d ago | Press Release | $4.05 | awaiting T+20 | — | $3.99 (−1.48%) |
Oct 9, 2026 18d ago | SC 13G/A | $4.54 | awaiting T+20 | — | $3.99 (−12.11%) |
Jul 29, 2026 12w ago | Press Release | $5.18 | awaiting T+20 | — | $3.99 (−22.97%) |
May 6, 2026 24w ago | 8-K | $6.39 $6.09 | ▼ −4.69% | ▼ −7.83% | $3.99 (−37.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers